The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxel

Jagdev, S.P., Coleman, R.E. orcid.org/0000-0002-4275-1043, Shipman, C.M. et al. (2 more authors) (2001) The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxel. British Journal of Cancer, 84 (8). pp. 1126-1134. ISSN 0007-0920

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2001 Cancer Research Campaign. From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
Keywords: breast cancer; bisphosphonate; apoptosis; paclitaxel; in-vitro; mevalonate pathway; multiple-myeloma; skeletal morbidity; controlled trial; bone metastases; clodronate; pamidronate; adhesion; inhibit
Dates:
  • Published: 17 April 2001
  • Published (online): 17 April 2001
  • Accepted: 30 January 2001
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Department of Human Metabolism (Sheffield)
The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology (Sheffield)
The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 08 Aug 2016 11:22
Last Modified: 08 Aug 2016 11:22
Published Version: http://dx.doi.org/10.1054/bjoc.2001.1727
Status: Published
Publisher: Cancer Research UK
Refereed: Yes
Identification Number: https://doi.org/10.1054/bjoc.2001.1727

Share / Export

Statistics